Innovaccer
Total Raised
$650.68MInvestors Count
36Deal Terms
5Investments
1Funding, Valuation & Revenue
14 Fundings
Innovaccer has raised $650.68M over 14 rounds.
Innovaccer's latest funding round was a Secondary Market for on January 9, 2025.
Innovaccer's valuation in January 2025 was $3,175 - $3,450M.
Innovaccer's latest post-money valuation is from January 2025.
Sign up for a free demo to see Innovaccer's valuations in December 2021, February 2021 and more.
Innovaccer's 2025 revenue was $230M - $250M. Innovaccer's most recent revenue is from 2021.
Sign up for a free demo to see revenue data from 2025, 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/9/2025 | Secondary Market | 3 | ||||
1/9/2025 | Series F | $275M | $3,175 - $3,450M | 8 | ||
1/1/2025 | Shareholder Liquidity | $230M - $250M FY 2025 | 3 | |||
12/15/2021 | Series E | |||||
2/19/2021 | Series D |
Date | 1/9/2025 | 1/9/2025 | 1/1/2025 | 12/15/2021 | 2/19/2021 |
|---|---|---|---|---|---|
Round | Secondary Market | Series F | Shareholder Liquidity | Series E | Series D |
Amount | $275M | ||||
Investors | |||||
Valuation | $3,175 - $3,450M | ||||
Revenue | $230M - $250M FY 2025 | ||||
Sources | 3 | 8 | 3 |
Innovaccer Deal Terms
5 Deal Terms
Innovaccer's deal structure is available for 5 funding rounds, including their Series F from January 09, 2025.
Round | Series F | Series E | Series D | Series B | Series A |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series F | |||||||||||||||
Series E | |||||||||||||||
Series D | |||||||||||||||
Series B | |||||||||||||||
Series A |
Innovaccer Investors
36 Investors
Innovaccer has 36 investors. M12 invested in Innovaccer's Secondary Market funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/2/2018 | 1/9/2025 | 8 Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025) | Corporate Venture | California | ||
2/19/2021 | 1/9/2025 | 4 Series D, Series E (2021), Series F (2025), Secondary Market (2025) | Venture Capital | California | ||
1/9/2025 | 1/9/2025 | 2 Series F, Secondary Market (2025) | Corporation | Arizona | ||
Corporation | California | |||||
Corporate Venture | Washington |
First funding | 3/2/2018 | 2/19/2021 | 1/9/2025 | ||
|---|---|---|---|---|---|
Last Funding | 1/9/2025 | 1/9/2025 | 1/9/2025 | ||
Investor | |||||
Rounds | 8 Series B, Series B - II (2019), Series C (2019), Series C - II (2020), Series D (2021), Series E (2021), Series F (2025), Secondary Market (2025) | 4 Series D, Series E (2021), Series F (2025), Secondary Market (2025) | 2 Series F, Secondary Market (2025) | ||
Board Seats | |||||
Type | Corporate Venture | Venture Capital | Corporation | Corporation | Corporate Venture |
Location | California | California | Arizona | California | Washington |
Innovaccer Acquisitions
4 Acquisitions
Innovaccer acquired 4 companies. Their latest acquisition was Story Health on September 16, 2025.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/16/2025 | Series A | $26.6M | Acquired | 3 | ||
1/21/2025 | ||||||
3/12/2024 | ||||||
1/16/2024 | Series A |
Date | 9/16/2025 | 1/21/2025 | 3/12/2024 | 1/16/2024 |
|---|---|---|---|---|
Investment Stage | Series A | Series A | ||
Companies | ||||
Valuation | ||||
Total Funding | $26.6M | |||
Note | Acquired | |||
Sources | 3 |
Innovaccer Investments
1 Investments
Innovaccer has made 1 investments. Their latest investment was in Confido Health as part of their Series A on September 30, 2025.
Innovaccer Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/30/2025 | Series A | Confido Health | $10M | Yes | Blume Ventures, DeVC, MedMountain Ventures, Memora Health, Schema Ventures, Together Fund, Undisclosed Investors, and Vicus Ventures | 3 |
Date | 9/30/2025 |
|---|---|
Round | Series A |
Company | Confido Health |
Amount | $10M |
New? | Yes |
Co-Investors | Blume Ventures, DeVC, MedMountain Ventures, Memora Health, Schema Ventures, Together Fund, Undisclosed Investors, and Vicus Ventures |
Sources | 3 |
Compare Innovaccer to Competitors
CareMoat is a platform that provides data analytics-driven predictive modeling to offer insights for self-funded employers within the healthcare industry. The company assigns Nurse Champions to support employees and facilitates an application for health benefit management. CareMoat serves the self-insured employer sector, focusing on improving healthcare experiences and reducing costs. It was founded in 2019 and is based in Nashville, Tennessee.
Clinithink is a technology company specializing in artificial intelligence for the life sciences and healthcare sectors. The company offers AI solutions that analyze unstructured healthcare data. Clinithink serves the pharmaceutical and healthcare industries with its AI technology aimed at enhancing clinical trial processes, disease diagnosis, and revenue management. It was founded in 2009 and is based in Bridgend, United Kingdom.
Arcadia operates as a healthcare data platform that focuses on healthcare data and analytics. The company provides products including analytics dashboards, care management tools, and population health management solutions. Arcadia serves healthcare providers, payers, and government organizations with a focus on value-based care. It was founded in 2002 and is based in Boston, Massachusetts.
Inovalon operates in the healthcare industry, offering data-driven, cloud-based solutions. The company provides a platform that integrates national-scale connectivity, primary source data access, and analytics to support clinical outcomes and health economics. Inovalon's services cater to various sectors, including payers, providers, pharmacies, and life sciences organizations, providing tools for revenue cycle management, care quality management, and workforce management. Inovalon was formerly known as MedAssurant. It was founded in 1998 and is based in Bowie, Maryland.
athenahealth operates as a company providing healthcare technology solutions, including electronic health records, medical billing and practice management software, and patient engagement tools. The offerings aim to improve operations and patient care. athenahealth serves a variety of customers, including provider organizations, medical practices of different sizes, health systems, and healthcare payers. It was founded in 1997 and is based in Boston, Massachusetts.
Komodo Health focuses on providing data-driven insights in the healthcare sector. The company offers a software platform that analyzes a variety of data to provide insights for various healthcare stakeholders. These insights aim to assist life sciences, patient advocacy, healthcare practitioners, and payers in their efforts to support patient care and manage costs. It was founded in 2014 and is based in New York, New York.
Loading...